Is Most Parkinson's Disease Man-Made? Is Most Parkinson's Disease Man-Made?
Indu Subramanian interviews Ray Dorsey about the link between environmental toxins and Parkinson ' s disease and his advocacy work to end this disease.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 20, 2023 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Blood Test for MS Activity Gets FDA Breakthrough Designation Blood Test for MS Activity Gets FDA Breakthrough Designation
Roche ' s Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 15, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Renowned Philadelphia Oculoplastic Surgeon, Dr. John J.W. Lee, Named a 2023 Top Patient Rated Doctor by Find Local Doctors
This prestigious award recognizes Dr. Lee's exceptional skill and commitment to providing patients with the highest quality care. Dr. Lee is known for his expertise in Blepharoplasty (Eyelid Surgery) and exceptional outcomes with Facial Fillers and Neuromodulators. BRYN MAWR, Pa., Nov.... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 15, 2023 Category: Pharmaceuticals Tags: AWD Source Type: news
The Placebo Effect The Placebo Effect
I recently had a generic cold. I usually get a cough that lasts a few weeks afterward, and like most people, I try to do something about it. So I load up on various over-the-counter remedies.MDedge (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 15, 2023 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Sustained Benefit for Newly Approved Myasthenia Gravis Drug Sustained Benefit for Newly Approved Myasthenia Gravis Drug
Early responders to zilucoplan, the newly approved medication for myasthenia gravis have sustained benefit for up to 60 weeks, new analyses show.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 14, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news